ALVR

ALVR

USD

AlloVir Inc. Common Stock

$9.810+0.260 (2.723%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

No chart data available

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$9.550

High

$10.320

Low

$9.550

Volume

N/A

Company Fundamentals

Market Cap

49.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.02M

Exchange

NCM

Currency

USD

52-Week Range

Low $7.96Current $9.810High $24.15

Related News

GlobeNewswire

Kalaris and AlloVir Announce Stockholder Approval of Merger

PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of

View more
Kalaris and AlloVir Announce Stockholder Approval of Merger
PR Newswire

SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now

Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...

View more
SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, ALVR, WMPN, AVAV on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

View more
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, ALVR, WMPN, AVAV on Behalf of Shareholders